Furthermore, as evident from S7B–S7D Table, several late-type genes showed a significant, but opposite, association with prognosis in one or more cohorts compared to the initial analysis of breast cancer, exemplified by RPL10, EIF4B, GPBP1L1 in NSCLC and RPL3, RPS6 and STEAP1 in ovarian cancer. This evidence concerns the gene GPBP1L1 and breast carcinoma.